Sodium Carbonate → 1,1-Dioxo-3-butyl-3-ethyl-5-phenyl-7-bromo-8-(1-ethoxycarbonylethoxy)-2,3,4,5-tetrahydro-1,5-benzothiazepine
Reaction equation
C(=O)([O-])[O-].[Na+].[Na+].[CH2:7]([O:9][C:10](=[O:14])[CH:11](Br)[CH3:12])[CH3:8].[O:15]=[S:16]1(=[O:41])[C:22]2[CH:23]=[C:24]([OH:28])[C:25]([Br:27])=[CH:26][C:21]=2[N:20]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[CH2:19][C:18]([CH2:37][CH2:38][CH2:39][CH3:40])([CH2:35][CH3:36])[CH2:17]1>[Br-].C([N+](CCCC)(CCCC)CCCC)CCC.CC#N>[O:41]=[S:16]1(=[O:15])[C:22]2[CH:23]=[C:24]([O:28][CH:11]([C:10]([O:9][CH2:7][CH3:8])=[O:14])[CH3:12])[C:25]([Br:27])=[CH:26][C:21]=2[N:20]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[CH2:19][C:18]([CH2:37][CH2:38][CH2:39][CH3:40])([CH2:35][CH3:36])[CH2:17]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
Sodium carbonate (0.30 g, 2.83 mmol), 2-bromopropanoic acid ethyl ester (0.145 g, 0.796 mmol) and tetrabutylammonium bromide (0.022 g, 0.07 mmol) was added to a solution of 1,1-dioxo-3-butyl-3-ethyl-5-phenyl-7-bromo-8-hydroxy-2,3,4,5-tetrahydro-1,5-benzothiazepine (WO 96/16051; 0.300 g, 0.663 mmol) in MeCN (10 ml). The suspension was heated under reflux overnight. The solvent was evaporated and the crude mixture was extracted (DCM/H2O), dried. (MgSO4), evaporated and purified by flash chromatography (Hex:EtOAc-5:1) to give the title compound 0.346 g (95%) as a white solid. NMR 0.70–0.85 (m, 6H), 1.00–1.75 (m, 8H), 1.35 (t, 3H), 1.70 (d, 3H), 3.05–3.25 (m, 2H), 3.55–3.90 (m, 2H), 4.20–4.35 (m, 2H), 4.80 (q, 1H), 7.00–7.10 (m, 3H), 7.15 (s, 1H), 7.25–7.35 (m, 2H), 7.45 (s, 1H).
Workup
- temperatureThe suspension was heated
- temperatureunder reflux overnight
- customThe solvent was evaporated
- extractionthe crude mixture was extracted (DCM/H2O)
- customdried
- custom(MgSO4), evaporated
- custompurified by flash chromatography (Hex:EtOAc-5:1)
Sources & evidence
- ORD record
- ord-2f8d0839e8044f61b8f36d00c63bee07
- Source dataset
- uspto-grants-2007_03
- Patent number
- US07192945B2
Reaction notes
Loading…